EMvision Introduction Video, page-15

There are very few companies that hit all the crucial investment criteria on the  ASX.

EMV has it all.

Amazing tech- comes out of a reputable institution with over 10 years research

Management- Ron has done it before (NAN was a 100 bagger) , and Stuart is a genius.

Industry Support- GE has partnered to the tune of $1m (non-dilutive)  along with  hospitals

Government Support- Government has funded close to $2m in grants, and because stroke is such a hot topic there are more funding opportunities they can apply for. No cap raise anytime soon, if you want a piece of the action you got to buy on market.

Massive markets: Stroke and fatty liver are already huge markets and growing especially in the developing world.

Tight register/ Low mcap: The register looks to be the goods & the EV is extremely low compared to other companies on the ASX who just received ISO..Cough cough RAP.

In this market people will always find a reason not to buy, personally, I'm a fan of listing it in a bad market. Because in a good market everything flies, people take IPOs to flip, but in a bad market the people who put the funds in are not there for 20%, they are there for at least 4-5 times which is still only a $60m mcap. I expect I won't be the only one topping up tomorrow. DYOR